基本信息
浏览量:3
职业迁徙
个人简介
Andrew is one of the most distinguished and cited scientists in modern drug discovery. He invented and championed an automated and algorithmic approach to drug design and drug discovery. Prior to that, he spent 14 years at Pfizer and in academia, pioneering cutting-edge projects using data mining and machine learning in the pharmaceutical industry. His papers, published in Nature journals, are widely considered as pivotal points in the new paradigm of modern drug discovery.
研究兴趣
论文共 83 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Scott C. Faville, Kes Harris-Hamdscomb, Owain Harker, Stephanie Mattison, Hajie Tamorite, Joshua Bristowe, Daniel Daly, Raissa Ege, Haoyuan He, Julian Jones, Abby McCorkindale, Kerry Mei,
GEN Biotechnologyno. 3 (2022): 225-229
Martin A. Redhead,C. David Owen,Lennart Brewitz, Amelia H. Collette,Petra Lukacik,Claire Strain-Damerell,Sean W. Robinson,Patrick M. Collins,Philipp Schafer,Mark Swindells,Chris J. Radoux, Iva Navratilova Hopkins,
Roland E. Dolle, Denise Barrault,Neil Carragher,Paul Andrews,Daniel Ebner,Andrew Hopkins,Hirotatsu Kojima,Stephen Frye, Al Edwards,Peter I. Dosa,Gunda I. Georg,Vadim J. Gurvich,
Pierre Fons,Andy Bell,Michael Esquerre,Stephanie Versluys,Florie Bertrand, Iva Hopkins-Navratilova,Sean Robinson,Virgile Visentin, Adrian Schreyer,Richard Cox,Emilie Mirey,Emilie Pelissier,
ACS medicinal chemistry lettersno. 12 (2016): 1213-1218
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn